You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Dose dependant least neurotoxicity is found in and explain in detail?
i.e. (Bleomycin): (527-H17th)DOXORUBICIN (525-H17th)* Predictable myelosuppression* Alopecia, nausea, mucositis* Cardiotoxicy in the form of atrial and ventricular dysarrhythmias* Powerful vesicant with necrosis of tissue apparent 4-7 days after an extravasation* Dexrazoxane is an antidote to doxorubicin-induced extravasationBLEOMYCIN (Antibiotics) (525-H17th)* Fever and chills, facial flush, and Raynaud's phenomenon* Hypertension, anaphylaxis* Pulmonary fibrosis * ** Little myelosuppressionCISPLATIN - (524-H17th)* Renal impairment is common*** Hypomagnesemia, hypocalcemia and tetany** Neurotoxicity with stocking and glove sensory motor neuropathy**** Hearing loss (50%)** Highly emetic drugs * ** Myelosuppression is less* Chronic vascular toxicity (Raynaud's phenomenon, Coronary artery disease) is a more unusual toxicity* Cisplatin is accumulated by proximal tubular cells where it induces mitochondrial injury and causes apoptosis and necrosis of renal tubular cells - ARF* Cisplatin is mutagenic, teratogenic and carcinogenic - Secondary leukemias are reported with the use of cisplatin and the use of cisplatin or carbolatin based chemotherapy for women with ovarian cancer is associated with a fourfold increased risks of developing secondary leukemia (1433-Goodman Gilman 10th)* Cisplatin has been associated with the development of AML usually 4 years or more after treatment -Lawrence